Biomarker Testing and NSCLC, Part 1

Biomarker Testing and NSCLC, Part 1 – September 4, 2024

In This Episode

PeerPOV: The Pulse on Medicine is a weekly podcast series that features expert commentary on the latest healthcare news, landmark research, and more.

Today we are joined by Dr. Rajat Thawani. He discusses why biomarker testing is crucial in guiding treatment decisions for patients with ROS1 mutations in NSCLC. He also highlights how specialized biomarker testing teams enhance the identification and management of patients with ROS1-positive NSCLC by providing knowledge about resistance mechanisms and helping select appropriate therapies.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!

Thanks for listening!

EXPLORE OUR PODCAST NETWORK

PeerPOV: The Pulse on Medicine is a weekly podcast series that features expert commentary on the latest healthcare news, landmark research, and more.

DDx is medical shorthand for differential diagnosis, and this is a podcast about how doctors think and learn on the job.

Physician’s Weekly Podcast offers HCPs in-depth interviews with the most highly respected experts in the medical community, weighing in on landmark research, trending topics, and more.